These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 12778816)
1. [The relationship between iron metabolism in central nervous system and Parkinson's disease]. Wang J; Jiang H; Xie JX Sheng Li Ke Xue Jin Zhan; 2003 Jan; 34(1):67-70. PubMed ID: 12778816 [No Abstract] [Full Text] [Related]
3. Iron in the brain. Beard JL; Connor JR; Jones BC Nutr Rev; 1993 Jun; 51(6):157-70. PubMed ID: 8371846 [TBL] [Abstract][Full Text] [Related]
4. Iron and ageing: an introduction to iron regulatory mechanisms. Levenson CW; Tassabehji NM Ageing Res Rev; 2004 Jul; 3(3):251-63. PubMed ID: 15231236 [TBL] [Abstract][Full Text] [Related]
5. Lactoferrin, lactoferrin receptors and iron metabolism. Iyer S; Lönnerdal B Eur J Clin Nutr; 1993 Apr; 47(4):232-41. PubMed ID: 8491159 [No Abstract] [Full Text] [Related]
6. Alteration in iron metabolism during retinal degeneration in rd10 mouse. Deleon E; Lederman M; Berenstein E; Meir T; Chevion M; Chowers I Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1360-5. PubMed ID: 18997094 [TBL] [Abstract][Full Text] [Related]
8. Lens epithelial cells synthesize and secrete ceruloplasmin: effects of ceruloplasmin and transferrin on iron efflux and intracellular iron dynamics. Harned J; Fleisher LN; McGahan MC Exp Eye Res; 2006 Oct; 83(4):721-7. PubMed ID: 16806171 [TBL] [Abstract][Full Text] [Related]
10. Transferrin metabolism and the liver. Aisen P Semin Liver Dis; 1984 Aug; 4(3):193-206. PubMed ID: 6385268 [No Abstract] [Full Text] [Related]
11. Iron trafficking inside the brain. Moos T; Rosengren Nielsen T; Skjørringe T; Morgan EH J Neurochem; 2007 Dec; 103(5):1730-40. PubMed ID: 17953660 [TBL] [Abstract][Full Text] [Related]
12. The physiology of iron, transferrin, and ferritin. van Eijk HG; de Jong G Biol Trace Elem Res; 1992 Oct; 35(1):13-24. PubMed ID: 1384624 [TBL] [Abstract][Full Text] [Related]
13. Central and peripheral autonomic integrity in Parkinson's disease. Adhiyaman V; Hobson P; Meara RJ Age Ageing; 2008 Sep; 37(5):578-81. PubMed ID: 18687873 [No Abstract] [Full Text] [Related]
14. What is the advantage of having melanin in parts of the central nervous system (e.g. substantia nigra)? Costin GE IUBMB Life; 2004 Jan; 56(1):47-9. PubMed ID: 14992380 [No Abstract] [Full Text] [Related]
15. [Physiological importance of transferrin]. Theobald K; König W Dtsch Med Wochenschr; 1985 Oct; 110(41):1581-6. PubMed ID: 2994976 [No Abstract] [Full Text] [Related]
16. Transferrin: structure, function and potential therapeutic actions. Gomme PT; McCann KB; Bertolini J Drug Discov Today; 2005 Feb; 10(4):267-73. PubMed ID: 15708745 [TBL] [Abstract][Full Text] [Related]
17. [Iron metabolism and metalloproteins (review)]. Buglanov AA Vopr Med Khim; 1988; 34(3):2-7. PubMed ID: 3047970 [TBL] [Abstract][Full Text] [Related]
18. Divalent metal transporter, iron, and Parkinson's disease: a pathological relationship. Lee HP; Zhu X; Liu G; Chen SG; Perry G; Smith MA; Lee HG Cell Res; 2010 Apr; 20(4):397-9. PubMed ID: 20357807 [No Abstract] [Full Text] [Related]
19. [Lactoferrin: advances and physiopathologic perspectives]. Camacho Siles J; Fernández Zamorano A; Arnalich Fernández F Rev Clin Esp; 1984 Nov 15-30; 175(3-4):119-22. PubMed ID: 6397788 [No Abstract] [Full Text] [Related]
20. Transferrins and defence against infection. Brock JH; Mainou-Fowler T; McGregor SJ Ann Ist Super Sanita; 1987; 23(4):935-41. PubMed ID: 3330652 [No Abstract] [Full Text] [Related] [Next] [New Search]